GSK Oral Care Buoys Flagging Smoking Cessation Franchise
This article was originally published in The Tan Sheet
GlaxoSmithKline oral care sales rose 6% worldwide to $976 mil. in 2000 with Aquafresh sales increasing 13%, while the firm's nicotine replacement franchise continued its year-long downward trend.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC